Cargando…
Generation and characterization of a highly effective protein substrate for analysis of FLT3 activity
BACKGROUND: Gain-of-function mutations of tyrosine kinase FLT3 are frequently found in acute myeloid leukemia (AML). This has made FLT3 an important marker for disease diagnosis and a highly attractive target for therapeutic drug development. This study is intended to generate a sensitive substrate...
Autores principales: | Chen, Yun, Guo, Yao, Han, Jiayu, Ho, Wanting Tina, Li, Shibo, Fu, Xueqi, Zhao, Zhizhuang Joe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419602/ https://www.ncbi.nlm.nih.gov/pubmed/22800464 http://dx.doi.org/10.1186/1756-8722-5-39 |
Ejemplares similares
-
JAK2V617F and p53 mutations coexist in erythroleukemia and megakaryoblastic leukemic cell lines
por: Zhao, Wanke, et al.
Publicado: (2012) -
Identification of an orally available compound with potent and broad FLT3 inhibition activity
por: Chen, Yun, et al.
Publicado: (2015) -
SU11652 Inhibits tyrosine kinase activity of FLT3 and growth of MV-4-11 cells
por: Guo, Yao, et al.
Publicado: (2012) -
Synergistic effect of BCL2 and FLT3 co-inhibition in acute myeloid leukemia
por: Brinton, Lindsey T., et al.
Publicado: (2020) -
Generation and Characterization of a JAK2V617F-Containing Erythroleukemia Cell Line
por: Zhao, Wanke, et al.
Publicado: (2014)